A Multinational Observational Study Characterizing Utilization and Effectiveness Outcomes in Patients with Metastatic Breast Cancer Receiving Abemaciclib
Phase 4
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000049797
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who received treatment with abemaciclib as part of a clinical trial 2.Patients who participated in a clinical trial any time after the initiation of abemaciclib treatment 3.Patients who benefited from an early access program for abemaciclib treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method